FAM129B Antibody兔多抗能识别内源性总FAM129B蛋白。该多克隆抗体通过使用与人源Fam129B蛋白谷氨酸(705位点)附近残基相一致的合成肽段免疫动物而获得。该抗体经蛋白A和肽亲和层析纯化。FAM129B/Niban-like protein 1(序列相似度 129的家族成员B)属于无显著特征的Niban蛋白家族,包括FAM129A/Niban、FAM129C/Niban-like protein 2。FAM129A/Niban蛋白参与ER应激反应,并且在甲状腺癌中蛋白水平被上调(1,2)。FAM129C/Niban-like protein 2在B细胞中优先表达,是五个生物标记物其中的一个,在大肠癌病人的全血中该蛋白水平被上调(3,4)。FAM129B蛋白广泛表达,被证实是黑色素瘤细胞中B-Raf蛋白的下游靶点(5)。尽管FAM129B蛋白不能调节细胞生长和分化,但是被B-Raf蛋白磷酸化的FAM129B蛋白对黑色素瘤细胞系和非黑色素瘤细胞系的侵袭潜能 十分重要(5)。黑色素瘤细胞中FAM129B蛋白的消除严重削弱了细胞外基质中B-Raf/MEK/Erk依赖型入侵(5)。
FAM129B Antibody recognizes endogenous levels of total FAM129B protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Glu705 of human Fam129B protein. Antibodies were purified by protein A and peptide affinity chromatography.
Background
FAM129B/Niban-like protein 1 (family with sequence similarity 129, member B) belongs to a poorly characterized family of Niban proteins that also includes FAM129A/Niban and FAM129C/Niban-like protein 2. FAM129A/Niban is implicated in the ER stress response and is upregulated at the protein level in thyroid carcinoma (1,2). FAM129C/Niban-like protein 2 is preferentially expressed in B-cells and is one of five biomarkers upregulated in whole blood from patients with colorectal carcinoma (3,4). FAM129B is broadly expressed and has been shown to be a downstream target of B-Raf in melanoma cells (5). Though FAM129B does not appear to regulate cell growth and division, phosphorylation of FAM129B by B-Raf is essential for the invasive potential of melanoma and non-melanoma cell lines (5). Deletion of FAM129B in melanoma cells significantly impairs B-Raf/MEK/Erk-dependent invasion into the extracellular matrix (5).